CGB 0.00% 2.1¢ cann global limited

Ann: Request For Voluntary Suspension extension 7 days, page-53

  1. 1,239 Posts.
    lightbulb Created with Sketch. 196
    Absolutely agree with you there. What started as a Bauxite Company is fast becoming the most consolidated Medical Cannabis Company in Australia via it's 55% holding in MCL imo.

    MCL, with it's own Cannabis Seed Bank being the driver of this huge change has

    1) Successfully marketed and commenced selling it's VitaHemp range of products in Australia.
    2) Established VitaCann to handle it's medical product range.
    3) Through VitaCann entered an exclusive JV partnership with CannTab Canada, to import, market and sell their products in Australia, with first right to distribute through Asia.
    4)Through VitaCann signed a binding agreement with Burleigh Heads Cannabis to use it's import license to import and store it's first CannTab drugs from Canada.
    5) Entered into an agreement with Algae Tec Ltd to develop MC products for animals.
    6) Signed strategic partnership with EndoCRO Ltd in Israel R&D
    7) Through it's subsidiary MCRG signed a Research Funding Agreement with the R&D Foundation Technion Institute Haifa,Israel, to the tune of US$3Million over 3 years

    With all the above in mind the only strategic acquisition that would add immediate value to MCL imo, would be for the Company that has the import licenses and permits in place, that being Burleigh Heads Cannabis.
    With materially significant news on the way I am more than happy to wait this out for however long it takes,
    AIMOHO GLTAH
 
watchlist Created with Sketch. Add CGB (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.